Medicine and Dentistry
Circulating Tumor Cell
100%
Patient
52%
Cells
37%
Neoplasm
36%
Prostate Cancer
23%
Diagnosis
19%
Metastatic Breast Cancer
16%
Non Small Cell Lung Cancer
16%
Breast Cancer
16%
Therapeutic Procedure
16%
Leukapheresis
15%
Overall Survival
15%
Survival
14%
Inpatient
12%
Epithelial Cell Adhesion Molecule
12%
Surface Plasmon Resonance
11%
Biological Marker
10%
Malignant Neoplasm
10%
Cell Count
10%
Castration Resistant Prostate Cancer
9%
Metastatic Carcinoma
9%
Health Care Cost
9%
Analysis
8%
Chemotherapy
8%
Association
8%
Liquid Biopsy
8%
Combination Therapy
8%
Chemotherapeutic Agent
7%
Drug
7%
Surgery
7%
Colorectal Cancer
7%
Metastatic Colorectal Cancer
6%
Assessment
6%
Programmed Cell Death
6%
Hazard Ratio
6%
Disease
5%
Raman Spectrometry
5%
Flow Cytometry
5%
Leukocyte
5%
Tumor Cell
5%
Pooled Analysis
5%
Progression Free Survival
5%
Cytokeratin
5%
Biochemistry, Genetics and Molecular Biology
Sample
27%
Antibody
19%
Overall Survival
17%
Liquid
17%
Cell Count
16%
Surface Plasmon Resonance
15%
Cancer Cell
13%
Leukapheresis
11%
Survival
11%
DNA
10%
Gene Amplification
10%
Flow Cytometry
10%
Time
9%
Surface Property
9%
Sample Preparation
9%
Association
7%
Epithelial Cell Adhesion Molecule
7%
Raman Spectroscopy
7%
Scanning Electron Microscopy
7%
Phenotype
7%
Development
6%
Leukocytes
6%
Cytokeratin
6%
Apoptosis
6%
Volume
5%
Comprehension
5%
Morphology
5%
Software
5%
